A 152 (see companion bill S 1763) – New Jersey
Introduced: 2022 Status: In Process
Requires Mandated Health Benefits Advisory Commission to study financial impact of all enacted mandated health benefits. The analysis and review of each mandated health benefit shall include: · the impact of the mandated health benefit …
A 1534 (see companion bill S 1167) – New Jersey
Introduced: 2022 Status: In Process
Establishes Prescription Drug Review Commission; requires production costs be reported for certain prescription drugs.
A 1535 (see companion bill S 2120) – New Jersey
Introduced: 2018 Status: Inactive / Dead
Requires cost disclosures by health care providers under certain circumstances; applies certain restrictions to charges for medical supplies. This bill prohibits health care facilities and health care professionals from charging any amount for: (1) a …
A 1571 (see companion bill S 963) – New Jersey
Introduced: 2018 Status: Inactive / Dead
REQUIRES AUDITS OF MANAGED CARE PLAN PROVIDER NETWORKS. If the audit finds that a carrier failed to maintain an adequate network in accordance with applicable federal or State law, including specialists as enumerated in N.J.A.C.11:24-6.2, the …
A 1591 – New Jersey
Introduced: 2018 Status: Inactive / Dead
PERMITS REGISTERED SURGICAL PRACTICES TO CONVERT TO OR COMBINE WITH AMBULATORY CARE FACILITIES; PROVIDES FOR PHASED-IN GROSS RECEIPTS ASSESSMENT; AUTHORIZES NON-PROFIT HOSPITALS TO ACQUIRE JOINT OWNERSHIP INTEREST IN PRACTICES. This bill authorizes surgical practices registered …
A 1669 – New Jersey
Introduced: 2020 Status: Inactive / Dead
Requires health insurers to limit copayments for insulin.
A 169 – New Jersey
Introduced: 2022 Status: In Process
This bill would expand the availability of the NJ FamilyCare Advantage program. The program provides an opportunity for individuals to purchase health care coverage through the Medicaid program. This coverage would be known as the …
A 1714 – New Jersey
Introduced: 2018 Status: Inactive / Dead
REQUIRES HEALTH INSURANCE CARRIERS TO COMPLY WITH CERTAIN NETWORK ADEQUACY REQUIREMENTS. The bill prohibits the Commissioner of Banking and Insurance from issuing conditional approval of provider network adequacy. The bill provides that in the case …
A 1720 (see companion bill S 972) – New Jersey
Introduced: 2018 Status: Inactive / Dead
REGULATES PHYSICIAN PROFILING PROGRAMS USED BY MANAGED CARE NETWORKS. Physician profiling programs are relatively new, and are designed to evaluate physicians participating in managed care plan networks, by measuring physicians’ performance based on quality and …
A 1733 (see companion bill S 626) – New Jersey
Introduced: 2018 Status: Inactive / Dead
Clarifies prohibition on preexisting condition exclusions in health insurance policies. This bill clarifies that a health insurer shall not impose, or include in its insurance policies, any provision excluding coverage for a preexisting condition. The …
A 1745 (see companion bill S 334) – New Jersey
Introduced: 2022 Status: In Process
This bill requires carriers to pass prescription drug savings on to consumers. The bill provides that all compensation paid by a pharmaceutical manufacturer to a pharmaceutical benefits manager as a result of negotiations of a …
A 1747 (see companion bill S 329) – New Jersey
Introduced: 2022 Status: In Process
This bill establishes the Prescription Drug Affordability Board (Board), which will be charged with protecting New Jersey residents, State and local governments, health benefits plans, health care providers, licensed pharmacies, and other stakeholders within the …
A 1762 (see companion bill S 2032) – New Jersey
Introduced: 2022 Status: In Process
This bill requires health insurance carriers to offer a clear cost share plan for individual health benefits plans. A clear cost share plan is a plan design that includes a set of annual copayments, coinsurance, …
A 1811 (see companion bill S 1182) – New Jersey
Introduced: 2022 Status: In Process
This bill requires health insurance carriers to provide continued coverage of prescription drugs for covered persons diagnosed with a complex or chronic medical condition or a rare disease.
A 1845 – New Jersey
Introduced: 2022 Status: In Process
Limits amount paid by covered persons for purchase of insulin drugs and epinephrine; requires Division of Consumer Affairs to investigate insulin prices.
A 1854 (see companion bill S 3622) – New Jersey
Introduced: 2020 Status: Inactive / Dead
Requires insurers to reimburse for medically necessary emergency and urgent care health care services in outpatient settings. This bill provides that, in the case of a request for authorization for a covered person who is …